SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001439222-21-000066
Filing Date
2021-08-05
Accepted
2021-08-05 16:16:39
Documents
2
Period of Report
2021-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162819452177536.html 3  
1 FORM 3 wf-form3_162819452177536.xml 3 13544
2 POA T WASHBURN ex-24.htm EX-24 4261
  Complete submission text file 0001439222-21-000066.txt   19272
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Washburn Theodore James Jr. (Reporting) CIK: 0001874199 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 211148425